ATRS
Antares Pharma, Inc.
ATRS
ATRS
Delisted
ATRS was delisted on the 23rd of May, 2022.
82 hedge funds and large institutions have $76.7M invested in Antares Pharma, Inc. in 2014 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 24 increasing their positions, 30 reducing their positions, and 14 closing their positions.
Holders
82
Holders Change
-3
Holders Change %
-3.53%
% of All Funds
2.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
24
Reduced
30
Closed
14
Calls
$14K
Puts
$354K
Net Calls
-$340K
Net Calls Change
+$117K
Top Buyers
| 1 |
GTC
1
Ghost Tree Capital
New York
|
$2.01M |
| 2 |
BC
2
Broadfin Capital
New York
|
$6.77M |
| 3 |
3
Renaissance Technologies
New York
|
$267K |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$537K |
| 5 |
TC
5
TFS Capital
West Chester,
Pennsylvania
|
$299K |
